glp 1 agonist history Timeline of GLP-1 discovery and clinical development. (a) Key events in The expanding landscape of GLP-1
Description
J Inflammation Res (2021) 14:227787
IKK, inhibitor kappa B kinase
These medications work by increasing feelings of fullness by slowing the rate at which the stomach empties, which can help reduce the urge to overeat
Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study
Whether hyperglycaemia itself directly affects the pathogenesis of atherosclerosis and heart failure remains inconclusive
